Loading...

Cyfuse Biomedical K.K.

4892.TJPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥673.00
¥20.00(3.06%)

Cyfuse Biomedical K.K. (4892.T) Company Profile & Overview

Explore Cyfuse Biomedical K.K.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Cyfuse Biomedical K.K. (4892.T) Company Profile & Overview

Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOShizuka Akieda

Contact Information

81 3 6435 1885
Sumitomo Fudosan Mita Twin Building, Tokyo, 108-6301

Company Facts

21 Employees
IPO DateDec 1, 2022
CountryJP
Actively Trading

Frequently Asked Questions

;